Oncotarget welcomes new editorial board members

BUFFALO, NY – July 22, 2024 – Oncotarget proudly welcomes new members to our esteemed Editorial Board, including our new Co-Editor-in-Chief, Dr. Wafik S. El-Deiry.

Joining Dr. El-Deiry on Oncotarget’s Editorial Board are Dr. Trever Bivona, Dr. Phillip Buckhaults, Dr. Fred Bunz, Dr. Jonathan Chernoff, Dr. Stephen G. Chun, Dr. Nathan Dolloff, Dr. Peiwen Fei, Dr. Justin D. Lathia, Dr. Bora Lim, Dr. Jia (Jenny) Liu, Dr. Hui-Wen Lo, Dr. Emil Lou, Dr. Anirban Maitra, Dr. Ruben A. Mesa, and Dr. Yashbir Singh.

To learn more about our outstanding members, please visit our Editorial Board page.

In celebration of the new additions to Oncotarget’s Editorial Board, we are excited to offer a special discount of 50% on all publication fees until the end of the year. This is our way of saying thank you to our supporters! 

To learn about how to publish with Oncotarget, please visit our Editorial Policies page.

About Oncotarget:

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

To learn more about Oncotarget, please visit Oncotarget.com and connect with us on social media at:

• X
• Facebook
• YouTube
• Instagram
• LinkedIn
• Pinterest
• Reddit
• Spotify, and available wherever you listen to podcasts
   

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact [email protected].

Oncotarget Journal Office

6666 East Quaker Street., Suite 1

Orchard Park, NY 14127

Phone: 1-800-922-0957 (option 2)

###